CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −8,222 | $36.67 | $302K | 38,254 |
| 2024-03-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −22,000 | 20,627 | ||
| 2024-03-01 | Sturmer Michael E PRESIDENT | Sale 10b5-1 | −11,009 | $36.63 | $403K | 141,738 |
| 2024-02-28 | Swartz Allison EVP, GC | Shares withheld for taxes | −1,509 | $40.79 | $62K | 53,083 |
| 2024-02-26 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −224 | $38.67 | $9K | 43,647 |
| 2024-02-26 | Sturmer Michael E PRESIDENT | Shares withheld for taxes | −5,785 | $38.67 | $224K | 152,747 |
| 2024-02-06 | Sturmer Michael E PRESIDENT | Sale 10b5-1 | −2,260 | $40.00 | $90K | 158,532 |
| 2024-02-05 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +20,000 | $3.95 | $79K | 106,312 |
| 2024-02-05 | Schlanger David J Executive Chairman | Sale 10b5-1 | −14,138 | $38.35 | $542K | 92,174 |
| 2024-02-05 | Schlanger David J Executive Chairman | Sale 10b5-1 | −5,862 | $38.86 | $228K | 86,312 |
| 2024-02-05 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −20,000 | 1,390,022 | ||
| 2024-02-02 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +30,000 | $3.95 | $119K | 116,312 |
| 2024-02-02 | Schlanger David J Executive Chairman | Sale 10b5-1 | −16,741 | $38.66 | $647K | 99,571 |
| 2024-02-02 | Schlanger David J Executive Chairman | Sale 10b5-1 | −13,259 | $39.24 | $520K | 86,312 |
| 2024-02-02 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −30,000 | 1,410,022 | ||
| 2024-02-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +22,000 | $3.95 | $87K | 68,871 |
| 2024-02-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes 10b5-1 | −12,349 | $38.10 | $470K | 56,522 |
| 2024-02-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −9,651 | $37.83 | $365K | 46,871 |
| 2024-02-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −3,000 | $37.89 | $114K | 43,871 |
| 2024-02-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −22,000 | 42,627 |
Page 15 of 77 · 1,524 trades